Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
EARLY_PHASE1
100 participants
INTERVENTIONAL
2009-01-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Maturation of Follicles After Transplantation of Ovarian Tissue Into the Pelvic Wall and the Ovary
NCT02780791
Transplantation of Frozen Thawed Ovarian Tissue High Reproductive Performance
NCT02659592
Ovarian Tissue Cryopreservation in the Setting of Gender-affirming Therapy
NCT05863676
Ovarian Tissue Cryopreservation for Fertility Preservation
NCT05875155
Ovarian Tissue Cryopreservation for Fertility Preservation in Girls and Women
NCT05434936
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ovarian transplantation
tissue will be used for xenotransplantation or in vitro culture
ovarian transplantation
ovarian xenotransplantation or in vitro culture
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ovarian transplantation
ovarian xenotransplantation or in vitro culture
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
5 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Israel Science Foundation
OTHER
Hadassah Medical Organization
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hadassah Medical Organization
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0530-08-HMO- CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.